These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 15798559)

  • 1. Interest of therapeutic plasmapheresis in a chronic hemodialysis patient with severe bullous pemphigoid.
    Ahmadpoor P; Beck M; Michel M; Pambrun E; Stoebner P; Moranne O
    J Clin Apher; 2024 Jun; 39(3):e22133. PubMed ID: 38881050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocytic infiltration as a marker of disease severity in patients with bullous pemphigoid-A case series.
    Mathur M; Thakur N; Das G; Paudel S; Jaiswal S
    Clin Case Rep; 2024 Jun; 12(6):e9084. PubMed ID: 38883217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bullous pemphigoid-like skin rash associated with Rivaroxaban use in a very elderly patient with multimorbidity and chronic kidney disease: A case report.
    Chohan SA; Balasubramanian D; Ee S
    Clin Case Rep; 2020 Apr; 8(4):725-730. PubMed ID: 32274046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional decline among bullous pemphigoid patients: A retrospective monocentric cohort study.
    Ouakrat R; Peiffer B; David JP; Belmondo T; Sbidian E; Canouï-Poitrine F; Ingen-Housz-Oro S
    J Eur Acad Dermatol Venereol; 2024 Jul; ():. PubMed ID: 38953405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Navigating through the challenges of bullous pemphigoid and breast cancer in the elderly.
    Yoo LJH; Grechin C; Kearney N; Orr E; Ryan SL; O'Kane M
    Clin Exp Dermatol; 2024 Mar; ():. PubMed ID: 38549551
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of the relationship between serum eosinophil and D-dimer levels and demographic and clinical characteristics in bullous pemphigoid patients.
    Oktem A; Erkanoglu GL; Akay BN
    J Eur Acad Dermatol Venereol; 2024 Apr; ():. PubMed ID: 38558459
    [No Abstract]   [Full Text] [Related]  

  • 7. PD-1/PD-L1 Checkpoint Inhibition Associated Bullous Pemphigoid: A Propensity Matched Retrospective Cohort Study.
    Sarkovics K; Kolodney JA; Kolodney MS
    Br J Dermatol; 2024 Apr; ():. PubMed ID: 38644763
    [No Abstract]   [Full Text] [Related]  

  • 8. Pembrolizumab-Induced Hypertrophic Lichenoid Dermatitis and Bullous Pemphigoid in One Patient.
    Alsabbagh M; Bava A; Ansari S
    Indian Dermatol Online J; 2024; 15(3):546-548. PubMed ID: 38845635
    [No Abstract]   [Full Text] [Related]  

  • 9. Bullous pemphigoid in younger adults: three case reports.
    Zanella RR; Xavier TA; Tebcherani AJ; Aoki V; Sanchez AP
    An Bras Dermatol; 2011; 86(2):355-8. PubMed ID: 21603823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Cross-Sectional Study to Correlate Disease Severity in Bullous Pemphigoid Patients with Serum Levels of Autoantibodies Against BP180 and BP230.
    Muhammed N; Korgaonkar S; Pradhan V; Khopkar US
    Indian Dermatol Online J; 2021; 12(5):696-700. PubMed ID: 34667755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Systematic Review of Drug-Induced Pemphigoid.
    Verheyden MJ; Bilgic A; Murrell DF
    Acta Derm Venereol; 2020 Aug; 100(15):adv00224. PubMed ID: 32176310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of Psoriasis and Bullous Diseases.
    Dainichi T; Kabashima K
    Front Med (Lausanne); 2018; 5():222. PubMed ID: 30135860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collagen XVII: a shared antigen in neurodermatological interactions?
    Seppänen A
    Clin Dev Immunol; 2013; 2013():240570. PubMed ID: 23878581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A severe course of bullous pemphigoid in a young man].
    Eigelshoven S; Bruch-Gerharz D; Enderlein E; Ruzicka T; Büchau AS; Hertl M; Reifenberger J; Schulte KW
    Hautarzt; 2006 Apr; 57(4):320-2. PubMed ID: 16523275
    [No Abstract]   [Full Text] [Related]  

  • 15. [Bullous pemphigoid in young patients: a retrospective study of 74 cases].
    Bourdon-Lanoy E; Roujeau JC; Joly P; Guillaume JC; Bernard P; Prost C; Tancrède-Bohin E; Delaporte E; Picard-Dahan C; Albes B; Bedane C; Doutre MS; Chosidow O; Lok C; Pauwels C; Chevrand-Breton J; Sassolas B; Richard MA
    Ann Dermatol Venereol; 2005 Feb; 132(2):115-22. PubMed ID: 15798559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory Diagnosis and Clinical Profile of Anti-p200 Pemphigoid.
    Meijer JM; Diercks GF; Schmidt E; Pas HH; Jonkman MF
    JAMA Dermatol; 2016 Aug; 152(8):897-904. PubMed ID: 27167149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-BP180 autoantibodies as a marker of poor prognosis in bullous pemphigoid: a cohort analysis of 94 elderly patients.
    Bernard P; Bedane C; Bonnetblanc JM
    Br J Dermatol; 1997 May; 136(5):694-8. PubMed ID: 9205501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical manifestations in 100 Japanese bullous pemphigoid cases in relation to autoantigen profiles.
    Tanaka M; Hashimoto T; Dykes PJ; Nishikawa T
    Clin Exp Dermatol; 1996 Jan; 21(1):23-7. PubMed ID: 8689764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management.
    Amber KT; Murrell DF; Schmidt E; Joly P; Borradori L
    Clin Rev Allergy Immunol; 2018 Feb; 54(1):26-51. PubMed ID: 28779299
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.